Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With PIK3CA Mutations and Overcoming Strategies. Kang M, Kim KJ, Sung JH, Nam M, et al. Anticancer Res 2025;45:1877-1896.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang M, Kim KJ, Sung JH, Nam M, et al. Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With PIK3CA Mutations and Overcoming Strategies. Anticancer Res 2025;45:1877-1896.
PMID: 40295072